Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

VRML $1.19 0.0790 +7.12%
TKMR $3.18 0.0769 +2.48%
CASC $1.22 0.0200 +1.67%
MRK $61.74 0.9867 +1.62%
TSRO $119.47 1.6700 +1.42%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

IMDZ $6.00 -0.5000 -7.69%
CLVS $30.10 -2.2137 -6.85%
DRNA $3.58 -0.2200 -5.79%
MNKD $0.52 -0.0270 -4.90%
SYRS $14.48 -0.6700 -4.42%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Merck Statement on FDA Approval of 2-Dose Regimen of GARDASIL® 9 for Girls and Boys 9 through 14 Years of Age

(Merck) Oct 7, 2016 - Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a 2-dose vaccination regimen for GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), for use in girls and boys 9 through 14 years of age.
read press statement 

Support for Marijuana Legalization Hits New Heights Ahead of November Election

(Washington Post/Wonkblog) Oct 12, 2016 - National support for marijuana legalization continues to rise, according to survey data released Wednesday by the Pew Research Center.
read article (free registration required) 

The Cost Of US Adult Vaccine Avoidance: $8.95 Billion In 2015

(Health Affairs Blog) Oct 12, 2016 - According to the Centers for Disease Control and Prevention (CDC), only 42 percent of US adults ages 18 and older received the flu vaccine in the 2015–16 flu season. This is just one example of US adults not receiving vaccinations at recommended levels, which can lead to avoidable costs of doctor visits, hospitalizations, and lost productivity.
read article 

Reviews Of Medical Studies May Be Tainted By Funders' Influence

(NPR/Shots blog) Oct 12, 2016 - When doctors want to help untangle confusing and sometimes contradictory findings in the scientific literature, they often turn to specially crafted summary studies.
read article 

Drug Coupons: Helping a Few at the Expense of Everyone

(New York Times/Upshot blog) Oct 12, 2016 - When a furor erupted over the rapidly rising price of EpiPens this summer, the drugmaker Mylan offered a solution: a coupon for the expensive drug.
read article 

Kantar Health Launches New Oncology Platform, Allowing Healthcare Companies to Better Understand Drug Opportunities

(Kantar Health) Oct 13, 2016 - Kantar Health, a leading global healthcare consulting and market research firm, today announced the launch of CancerLandscape™, offering fast navigation of large datasets to better understand oncology drug opportunities and the competitive landscape.
read corporate press release 

Dana-Farber Cancer Institute Announces Lung Cancer Research Collaboration

(Dana-Farber) Oct 12, 2016 - Dana-Farber Cancer Institute and Diichi Sankyo Company, Limited today announced a preclinical research collaboration focused on lung cancer.
read press release 

Regional Cancer Care Associates And Aetna Form Oncology Medical Home

(New Jersey Online) Oct 13, 2016 - Regional Cancer Care Associates (RCCA) and Aetna announced a collaboration to create an oncology medical home that is designed to improve the care experience for cancer patients.
read article 

Aptose Provides Update on FDA Clinical Hold of APTO-253

(StreetInsider) Oct 13, 2016 - Aptose Biosciences Inc. today announced that it received a response from the U.S. Food and Drug Administration (FDA) regarding the clinical hold of Aptose’s Phase 1b clinical trial of APTO-253 in patients with hematologic cancers requesting additional information and informing Aptose that the hold would not be removed until this information is submitted and reviewed.
read article 

The Case Against The Case Against Mammography

(Forbes) Oct 13, 2016 - The world’s leading medical journal has published yet another skewed analysis of mammography, overdiagnosis, and breast cancer trends. I’m disappointed that the New England Journal of Medicine would promote such an assumption-riddled, estimate-loaded piece to dissuade readers of screening’s value.
read article 

Welch Et Al. Data in NEJM Reinforces That Mammography Detects Breast Cancers Earlier and Saves Lives

(American College of Radiology) Oct 12, 2016 - The numerical data in Welch et al., published in the October 13 New England Journal of Medicine, clearly show that mammography screening catches more cancers early and reduces the number of women with cancers of advanced size.
read press release 

Urge Congress to Support Federal Research Funding in FY 2017

(ASCO in Action) Oct 13, 2016 - In advance of the ‘lame duck’ session scheduled after the November election, ASCO is continuing its outreach to Congress to urge lawmakers to include a funding increase for the National Institutes of Health (NIH) in the FY 2017 spending bill.
read article 

Novocure Enrolls First Patient In Phase 3 Pivotal Brain Metastases Trial

(TheStreet) Oct 12, 2016 - METIS phase 3 pivotal trial will study radiosurgery plus Tumor Treating Fields compared to radiosurgery alone for brain metastases from non-small cell lung cancer.
read article 

Research on Common Bacterium Opens Door to Fighting Gastric Cancer

(University of Georgia/UGA News) Oct 11, 2016 - A common bacterium that more than half of people have in their gut can use hydrogen gas present in the gastrointestinal tract to inject a cancer-causing toxin into otherwise healthy cells, according to a recently published study led by University of Georgia researchers.
read article 

Faulty Molecule Offers New Target for Treating Liver Cancer

(ICR [UK]) Oct 13, 2016 - Blocking a single faulty molecule in a biological process that drives the growth of advanced liver cancers could offer a new way to treat the disease, researchers have found.
read article 

New Findings Challenge Current View of How Pancreatic Cancer Develops

(OICR News [Canada]) Oct 12, 2016 - Researchers in the multidisciplinary PanCuRx research initiative at the Ontario Institute for Cancer Research and University Health Network’s Princess Margaret Cancer Centre, led by Dr. Faiyaz Notta and Dr. Steven Gallinger, today published new findings that challenge current beliefs about how and why pancreatic cancer is so aggressive.
read press release 

Freeze Therapy: An Alternative To Breast Cancer Surgery?

(St. Louis Post-Dispatch/HealthDay News) Oct 12, 2016 - A freezing technique known as cryoablation might be a viable alternative to lumpectomy for treating small, early stage breast cancers, researchers report.
read article 

Common Prostate Cancer Treatment Linked to Later Dementia, Researcher Says

(Stanford Medicine) Oct 13, 2016 - A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with.
read press release 

ASCO Issues New Guideline for Global Cervical Cancer Screening

(Medscape Medical News) Oct 12, 2016 - A new global guideline on screening for cervical cancer, which provides evidence-based recommendations for screening, follow-up, and treatment for high-risk lesions, has been released by the American Society of Clinical Oncology (ASCO).
read article (free registration required) 

New Report Questions Value of Mammograms

(NBC News) Oct 12, 2016 - A new report questioning the value of routine mammograms has generated an unusual amount of almost angry criticism from experts who say it will confuse women without adding any value to the debate.
read article 

Study Questions Value of Mammograms, Breast Cancer Screening

(CBS News/Associated Press) Oct 12, 2016 - A new study questions the value of mammograms for breast cancer screening. It concludes that a woman is more likely to be diagnosed with a small tumor that is not destined to grow than she is to have a true problem spotted early.
read article 

ASCO Issues Global Recommendations to Increase Cervical Cancer Screening

(ASCO) Oct 12, 2016 - The American Society of Clinical Oncology (ASCO) today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide.
read press release 

OncoGenex Announces Results From the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer

(OncoGenex) Oct 13, 2016 - OncoGenex Pharmaceuticals, Inc. announced today results from the final analysis of the Phase 3 ENSPIRIT trial of custirsen in patients whose non-small cell lung cancer (NSCLC) has progressed following initial treatments.
read corporate press release 

Clinical Takeaways From the ESMO Presidential Symposia

(Medscape Oncology/Commentary) Oct 10, 2016 - ESMO promised practice-changing clinical trials at their annual congress this year, and the final program delivered, particularly in lung cancer.
read article (free registration required) 

Tax Soda To Fight Obesity, WHO Urges Nations Around The Globe

(NPR/The Salt blog) Oct 11, 2016 - The World Health Organization has already urged us to cut back on sugar, limiting added sugars to no more than 10 percent of our daily calories.
read article